H01CB03 • lanreotide • Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues
Lanreotide is a somatostatin analog used to treat acromegaly and certain neuroendocrine tumors. It works by inhibiting the secretion of hormones such as growth hormone and reducing blood flow to neuroendocrine tumors.
The medication is administered as subcutaneous injections, usually once every 4 weeks, as directed by a doctor. The treatment is effective in controlling symptoms and slowing disease progression.
Side effects may include pain at the injection site, nausea, diarrhea, or fatigue. In rare cases, severe allergic reactions or gallstone formation may occur.
Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
Substance: lanreotide
Date of last drug list: 01-07-2013
Commercial code: W42504001
Concentration: 90mg
Pharmaceutical form: prolonged-release solution for injection
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).